General Information of the Compound
Compound ID |
CP0926811
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-((S)-Acetylamino)-hexanoic acid {[(4-amino-butyl)-({1-[{[1-(carbamoylmethyl-carbamoyl)-2-(1H-indol-3-yl)-ethylcarbamoyl]-methyl}-(3-guanidino-propyl)-carbamoyl]-2-phenyl-ethylcarbamoyl}-methyl)-carbamoyl]-methyl}-amide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C44H65N13O8
|
||||||||||||||||||
Molecular Weight |
904.087
|
||||||||||||||||||
Canonical SMILES |
CCCC[C@H](NC(C)=O)C(=O)NCC(=O)N(CCCCN)CC(=O)N[C@@H](Cc1ccccc1)C(=O)N(CCCN=C(N)N)CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(N)=O
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C44H65N13O8/c1-3-4-16-34(53-29(2)58)41(63)52-26-40(62)56(20-11-10-18-45)27-38(60)55-36(22-30-13-6-5-7-14-30)43(65)57(21-12-19-49-44(47)48)28-39(61)54-35(42(64)51-25-37(46)59)23-31-24-50-33-17-9-8-15-32(31)33/h5-9,13-15,17,24,34-36,50H,3-4,10-12,16,18-23,25-28,45H2,1-2H3,(H2,46,59)(H,51,64)(H,52,63)(H,53,58)(H,54,61)(H,55,60)(H4,47,48,49)/t34-,35-,36-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
NDPDYBVCEPLLQM-KVBYWJEESA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00914, Melanocortin receptor 4
Protein ID: PT01528, Melanocortin receptor 5